Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Cambridge Enterprise Limited investment portfolio
Cambridge Enterprise Limited has made numerous investments in companies such as Paragraf, Semarion, and Biomodal within the Health Tech sector.
unknown
Portfolio
19
Team
0
Portfolio (19)
| Company | Sector | Source | Last confirmed on |
|---|---|---|---|
| Barocal Ltd | Healthcare & Life Sciences | Confirmed | 2026-04-27 |
| Biomodal Limited BIOMODAL LIMITED is a life sciences technology and analytics company that develops DNA sequencing tools, specifically the "duet multiomics solution." This technology simultaneously reads genetic and epigenetic information from single, low-input DNA samples, providing comprehensive biological insights for life scientists and clinical developers in areas such as cancer research, neurodegenerative diseases, and precision medicine. | Healthcare & Life Sciences | Confirmed | 2025-03-26 |
Shareholding changes (4)
Cambridge Enterprise Limited's positions across portfolio companies2025
- ORDINARY 0 → 9,325
- ORDINARY 0 → 8,374
Articles (5)
- 16 May 2026
- Storm Therapeutics secures £9.2m for clinical stage RNA research9 May 2026Storm Therapeutics
- 30 Apr 2026
- Lucida Medical Secures Estimated £7.7m to Advance AI-Powered Prostate Cancer Diagnostics18 Apr 2026Lucida Medical
- Kodiaq Technologies Secures £150.4k Pre-Seed to Advance Long-Duration Flow Batteries10 Mar 2026Kodiaq Technologies